AstraZeneca Adds to Demands on Hospitals Seeking Drug Discounts

AstraZeneca Plc will soon require that hospitals and other health providers under a federal drug discount plan submit claims data for dispensing of the company’s drugs, joining other manufacturers in imposing policies seeking to monitor a program that has ballooned in recent years.

The policy, set to go into effect May 1, demands that all entities under the federal 340B Drug Pricing Program to submit claims data for specific medicines purchased from AstraZeneca. The plan expands the company’s requirement that previously targeted pharmacies that contract with 340B entities, aiming to minimize diversion and duplicate discounts under the program.

“As the ...